FSCPX
Price
$62.68
Change
+$0.58 (+0.93%)
Updated
Sep 11 closing price
Net Assets
713.2M
RYLSX
Price
$85.41
Change
+$0.60 (+0.71%)
Updated
Sep 11 closing price
Net Assets
4.82M
Interact to see
Advertisement

FSCPX vs RYLSX

FSCPX vs RYLSX Comparison Chart in %
View a ticker or compare two or three
VS
FSCPX vs. RYLSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCPX is a Hold and RYLSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSCPX has more cash in the bank: 713M vs. RYLSX (4.82M). RYLSX pays higher dividends than FSCPX: RYLSX (0.06) vs FSCPX (0.04). FSCPX was incepted earlier than RYLSX: FSCPX (36 years) vs RYLSX (22 years). RYLSX (1.69) is less costly to investors than FSCPX (0.69). RYLSX is a more actively managed with annual turnover of: 173.00 vs. FSCPX (21.00). FSCPX has a lower initial minimum investment than RYLSX: FSCPX (0) vs RYLSX (2500). RYLSX IRA initial investment is lower compared to FSCPX: RYLSX (1000) vs FSCPX (500). RYLSX annual gain was more profitable for investors over the last year : -10.13 vs. FSCPX (-12.43). RYLSX return over 5 years is better than : -6.41 vs. FSCPX (-13.39).
FSCPXRYLSXFSCPX / RYLSX
Total Expense Ratio0.691.6442%
Annual Report Gross Expense Ratio0.691.6941%
Fund Existence36 years22 years-
Gain YTD-10.156-5.672179%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRA500100050%
Net Assets713M4.82M14,796%
Annual Yield % from dividends0.040.0663%
Returns for 1 year-12.43-10.13123%
Returns for 3 years13.4226.4851%
Returns for 5 years-13.39-6.41209%
Returns for 10 years78.3354.46144%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDVCX12.870.12
+0.94%
Nomura Value C
TWEAX9.360.04
+0.43%
American Century Equity Income A
SUICX76.77N/A
N/A
DWS CROCI International C
ARIGX15.79N/A
N/A
Aristotle Growth Equity I
UIVQX13.31N/A
N/A
MFS Intrinsic Equity R4